PGF and Abnormal renal physiology: Therefore, in patients with renal dysfunction, who are likely to have high levels of VEGF and PlGF and chronic inflammatory conditions, aflibercept or dexamethasone implant should be considered as the first-line therapy for the treatment of DME.